Sanofi $SNY Holdings Lowered by TD Private Client Wealth LLC

TD Private Client Wealth LLC reduced its holdings in Sanofi (NASDAQ:SNY) by 15.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,009 shares of the company’s stock after selling 19,138 shares during the quarter. TD Private Client Wealth LLC’s holdings in Sanofi were worth $4,895,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in SNY. Flagship Harbor Advisors LLC bought a new stake in shares of Sanofi in the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC bought a new stake in shares of Sanofi in the 3rd quarter worth approximately $29,000. Palisade Asset Management LLC bought a new stake in shares of Sanofi in the 3rd quarter worth approximately $30,000. Sittner & Nelson LLC acquired a new stake in shares of Sanofi during the third quarter valued at approximately $47,000. Finally, Costello Asset Management INC raised its holdings in shares of Sanofi by 1,300.0% during the third quarter. Costello Asset Management INC now owns 1,400 shares of the company’s stock valued at $66,000 after acquiring an additional 1,300 shares during the period. 14.03% of the stock is currently owned by institutional investors.

Sanofi Price Performance

Shares of Sanofi stock opened at $43.54 on Tuesday. The firm has a fifty day simple moving average of $45.57 and a 200-day simple moving average of $47.38. The company has a current ratio of 1.01, a quick ratio of 0.22 and a debt-to-equity ratio of 0.17. Sanofi has a 1-year low of $42.33 and a 1-year high of $53.36. The stock has a market capitalization of $106.19 billion, a price-to-earnings ratio of 12.16, a PEG ratio of 1.05 and a beta of 0.35.

Sanofi Increases Dividend

The company also recently announced an annual dividend, which will be paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th will be issued a $2.4225 dividend. This represents a dividend yield of 559.0%. The ex-dividend date of this dividend is Monday, May 4th. This is a positive change from Sanofi’s previous annual dividend of $2.04. Sanofi’s payout ratio is currently 49.44%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Argus upgraded shares of Sanofi to a “strong-buy” rating in a report on Monday, April 27th. Bank of America lowered shares of Sanofi from a “buy” rating to a “neutral” rating in a report on Thursday, February 12th. Morgan Stanley set a $52.00 price target on shares of Sanofi in a report on Friday, May 1st. Wall Street Zen lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 21st. Finally, Citigroup restated a “neutral” rating on shares of Sanofi in a report on Monday, April 13th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $51.00.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.